<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR88829-0083 </DOCNO><DOCID>fr.8-29-88.f2.A1082</DOCID><TEXT><ITAG tagnum="69"><ITAG tagnum="41">[Docket No. 88D-0243]</ITAG><ITAG tagnum="52">Draft Guidance Document for Class III Contact Lenses; Availability</ITAG><ITAG tagnum="10"><T2>AGENCY: </T2>Food and Drug Administration.</ITAG><ITAG tagnum="10"><T2>ACTION: </T2>Notice of availability.</ITAG><ITAG tagnum="10"><T2>SUMMARY: </T2>The Food and Drug Administration (FDA) is announcingthe availability of a draft ``Guidance Document for Class III Contact Lenses,''prepared by FDA's Center for Devices and Radiological Health (CDRH). Thedocument provides guidance to the contact lens industry for evaluatingthe safety and effectiveness of class III contact lenses. The guidancedocument is being made available for public comment to provide CDRH's Divisionof Ophthalmic Devices with views to be considered in its development ofa final guidance document for class III contact lenses.</ITAG><ITAG tagnum="10"><T2>DATE: </T2>Comments may be submitted at any time; however, commentssubmitted by October 31, 1988 will be considered during preparation ofa final guidance document.</ITAG><ITAG tagnum="10"><T2>ADDRESS: </T2>The ``Guidance Document for Class III Contact Lenses''is available for public examination at, and written comments may be submittedto the Dockets Management Branch (HFA-305), Food and Drug Administration,Rm. 4-62, 5600 Fishers Lane, Rockville, MD 20857. Address written requestsfor single copies of the guidance document to the Division of Small ManufacturersAssistance, Center for Devices and Radiological Health (NFZ-220), Foodand Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 800-638-2041,calls from within MD 301-443-6597.</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT: </T2>David M. Whipple, Center forDevices and Radiological Health (HFZ-460), Food and Drug Administration,8757 Georgia Ave., Silver Spring, MD 20910, 301-427-7940.</ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION: </T2>The draft ``Guidance Document for ClassIII Contact Lenses'' is intended to provide the agency's suggested guidanceto enable manufacturer of a contract lens to conduct an adquate batteryof preclinical tests to ensure that patients are not placed at undue riskin a clinical trial, and to enable a manufacturer to conduct a clinicaltrial that will adequately demonstrate whether the lens is safe and effectivefor its intended use.The draft guidance document is being made available for public commentbefore being issued in final form. If, following the receipt of comments,the agency concludes that the guidance document reflects acceptable practicesand procedures for the preparation and submission of investigational deviceexemption applications and premarket approval applications for class IIIcontact lenses, the draft guidance document will be made final, and itsavailability will be announced in the <T4>Federal Register. </T4>FDA is making the draft guidance document available under 21 CFR 10.90(b).That section provides for use of guidelines to establish procedures ofgeneral applicability that are not legal requiements but are acceptableto the agency. A person may also choose to use alternative procedures eventhough they are not provided for in the guidance document. A person whochooses to do so may discuss the matter further with the agency to preventexpenditure of money and effort on an alternative procedure that the agencymay later determine to be unacceptable. Manufacturers are encouraged touse this opportunity to submit comments on the draft guidance document,if they have suggestions for its revision.Interested persons may submit comments on the draft guidance document atany time. However, comments submitted by October 31, 1988 will be consideredduring preparation of a final guidance document. Two copies of any commentsare to be submitted, except that individuals may submit single copies.Comments should be identified with the document number found in bracketsin the heading of this document. The draft guidance document and receivedcomments may be seen in the Dockets Management Branch (address above) between9 a.m. and 4 p.m., Monday through Friday.<ITAG tagnum="21">Dated: August 24, 1988.</ITAG><ITAG tagnum="6">John M. Taylor,</ITAG><ITAG tagnum="4">Associate Commissioner for Regulatory Affairs.</ITAG><ITAG tagnum="40">[FR Doc. 88-19685 Filed 8-29-88; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4160-01-M</ITAG></ITAG></ITAG></TEXT></DOC>